News | July 26, 2022
GlaxoSmithKline Pharmaceuticals Q1FY23 consolidated PAT at Rs. 119.28 Cr
GlaxoSmithKline Pharmaceuticals has reported total income of Rs. 772.71 crores during the period ended June 30, 2022
GlaxoSmithKline Pharmaceuticals has reported total income of Rs. 772.71 crores during the period ended June 30, 2022
Sun Pharma will receive from Cassiopea the exclusive right to develop and commercialize WINLEVI in Japan, Australia, New Zealand, Brazil, Mexico and Russia.
The Award reinforces Cadila’s digital initiatives which is backed by innovation, research & development and robust frameworks.
With this, the company can start selling Ibuprofen in the European markets.
The company now exceeds the sector benchmark for its overall ESG rating and for all three measures
The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China
Gansons is based in Thane (Maharashtra, India) with global representation in UK, USA, UAE, Central Asia, South Asia and South-East Asia.
The approval has been accorded by IFCI Limited for manufacturing of the product "7 ACA"
Manish led SeQuent since 2014 and played a major role in transforming the company
George Svokos joins Avet after serving as a strategic business advisor to numerous global healthcare companies
Subscribe To Our Newsletter & Stay Updated
